Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

OBJECTIVE: The study investigated the efficacy and safety of oral vinorelbine-cisplatin (OV-CDDP) and gemcitabine-cisplatin (GEM-CDDP) in patients with squamous non-small cell lung cancer (sq-NSCLC). PATIENTS AND METHODS: This was an open-label, prospective, multicenter, international phase II study...

Descripción completa

Detalles Bibliográficos
Autores principales: Grossi, Francesco, Jaśkiewicz, Piotr, Ferreira, Marion, Czyżewicz, Grzegorz, Kowalski, Dariusz, Ciuffreda, Libero, Garcia-Gomez, Ramon, Caruso, Salvatore, Bosch-Barrera, Joaquim, Gautier, Stéphanie, Ta Thanh Minh, Christine, Henriet, Sébastien, de Castro, Gilberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287271/
https://www.ncbi.nlm.nih.gov/pubmed/34349841
http://dx.doi.org/10.1177/17588359211022905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287271/
https://www.ncbi.nlm.nih.gov/pubmed/34349841
http://dx.doi.org/10.1177/17588359211022905

Ejemplares similares